Page last updated: 2024-10-30

mefenamic acid and Alloxan Diabetes

mefenamic acid has been researched along with Alloxan Diabetes in 1 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Mefenamic acid in plasma was assayed by high performance liquid chromatography."1.30The bioavailability and pharmacokinetics of mefenamic acid in alloxan-diabetic rabbits. ( Ahmad, M; Irfan, N; Jamshaid, M; Muzaffar, NA; Qamar, S, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qamar, S1
Irfan, N1
Ahmad, M1
Jamshaid, M1
Muzaffar, NA1

Other Studies

1 other study available for mefenamic acid and Alloxan Diabetes

ArticleYear
The bioavailability and pharmacokinetics of mefenamic acid in alloxan-diabetic rabbits.
    The Tokai journal of experimental and clinical medicine, 1997, Volume: 22, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Diabetes Mellitus, Experi

1997